ONC_AGCT1532

ONC AGCT1532 - A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Germ Cell Tumors

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.
Phase III
NCT02582697
Cancer
Pediatric
Brenda Wittman, M.D.
COG (Childrens Oncology Group)
Brittany Ledall
  • Alaska Research
  • Providence Alaska Medical Center